Examining prognostic indicators in MDS

ESH eLearning, Michael Pfeilstöcker, 348235

Controversial debate: Genetics versus epigenetics in myeloid disease - Chair

ESH eLearning, Uwe Platzbecker, 348232

Panel Discussion

ESH eLearning, Faculty / Presenters, 348231

Immunological mess in MDS; is there a target?

ESH eLearning, Shahram Kordasti, 348230

Bone biology and the osteo-hematopoietic niche

ESH eLearning, Ulrike Baschant, 348229

Panel Discussion

ESH eLearning, Faculty / Presenters, 348228

Druggable molecular targets in MDS and elderly AML) (IDH, TP53…)

ESH eLearning, Torsten Haferlach, 348227

Multiple acquired clonal steps to MDS, molecular architecture and its progression to AML

ESH eLearning, Oliver Kosmider, 348226

Panel Discussion

ESH eLearning, Faculty / Presenters, 348225

Relationships between inherited and acquired predisposition

ESH eLearning, Jaroslaw Maciejewski, 348224

Therapy related MDS and other environmental factors in MDS

ESH eLearning, Maria Teresa Voso, 348223

General discussion

ESH eLearning, Faculty / Presenters, 347827

Time limited vs continuous treatments

ESH eLearning, Barbara Eichhorst, 347826

Sequential vs combination treatments

ESH eLearning, William Wierda, 347825

MRD as a dynamic endpoint

ESH eLearning, Peter Hillmen, 347824

General discussion

ESH eLearning, Faculty / Presenters, 347823

Venetoclax

ESH eLearning, J.F. Seymour, 347821

PI3K

ESH eLearning, Jennifer Brown, 347820

Clonal evolution

ESH eLearning, Davide Rossi, 347819

General discussion

ESH eLearning, Faculty / Presenters, 347818

Gastroenterology

ESH eLearning, Stefano Fagiuoli, 347817

Infectious diseases

ESH eLearning, Michele Bartoletti, 347816

Dermatologist

ESH eLearning, Nicole Le, 347815

Cardiologist

ESH eLearning, Javid Moslehi, 347814

General discussion

ESH eLearning, Faculty / Presenters, 347813

CAR-T cells

ESH eLearning, Stephan Schuster, 347812

Novel inhibitors at preclinical level (MCL1 &CDK inhibitors)

ESH eLearning, Alexey Danilov, 347811

Next generation PI3K inhibitors

ESH eLearning, Peter Hillmen, 347810

General discussion

ESH eLearning, Faculty / Presenters, 347809

Immunomodulatory effects of kinase inhibitors

ESH eLearning, Adrian Wiestner, 347808

Role of T cells

ESH eLearning, Arnon Kater, 347807

General discussion

ESH eLearning, Faculty / Presenters, 347806

Short Oral Communication Sequential treatment with bendamustine, obinutuzumab (GA101) and ibrutinib in CLL: final results of the CLL2-BIG trial of the German CLL study group (GCLLSG)

ESH eLearning, Julia Von, 347805

Venetoclax/PI3K real world

ESH eLearning, Lindsey E. Roeker, 347804

Ibrutinib real world

ESH eLearning, Loïc Ysebaert, 347803

Ibrutinib trials

ESH eLearning, Alessandra Tedeschi, 347802

General discussion

ESH eLearning, Faculty / Presenters, 347801

MURANO and MRD

ESH eLearning, J.F. Seymour, 347799

Ibrutinib for a small subgroup only

ESH eLearning, Florence Cymbalista, 347798

Ibrutinib for everybody

ESH eLearning, Jennifer Woyach, 347797

General discussion

ESH eLearning, Faculty / Presenters, 347796

Next generation BTK inhibitors (covalent/non-covalent?)

ESH eLearning, Anthony Mato, 347795

The latest news of stereotypes

ESH eLearning, Kostas Stamatopoulos, 347794

General discussion

ESH eLearning, Faculty / Presenters, 347793

Risk stratification in CLL

ESH eLearning, Antonio Cuneo, 347792

Ibrutinib resistance

ESH eLearning, Jennifer Woyach, 347791

Genetic predisposition

ESH eLearning, Jennifer Brown, 347790

Discussion

ESH eLearning, Faculty / Presenters, 336807

Genetic predisposition for myeloid malignancies: clinical management

ESH eLearning, Lucy Godley, 336806

Genetic editing of haematopoietic stem cells. Are we getting there?

ESH eLearning, Matthew Porteus, 336805

Discussion

ESH eLearning, Faculty / Presenters, 336804

Novel complement inhibitors

ESH eLearning, Antonio Maria Risitano, 336803

Discussion

ESH eLearning, Faculty / Presenters, 336802

How to handle moderate aplastic anaemia

ESH eLearning, Britta Höchsmann, 336801

Transplantation for acquired SAA: are we making progress?

ESH eLearning, Andrea Bacigalupo, 336800

Discussion

ESH eLearning, Faculty / Presenters, 336799

Selected brief oral communication: The Metabolomic Status of the Differentiating Myeloid Lineage in MDS with Low and High Bone Marrow Blast Counts.

ESH eLearning, Aikaterini Poulaki, 336798

Health-related quality of life and its assessment in aplastic anaemia and paroxysmal nocturnal haemoglobinuria

ESH eLearning, Jens Panse, 336797

Impact of clonal haematopoiesis in aplastic anaemia

ESH eLearning, Jaroslaw Maciejewski, 336796

Innate immunity and clonal evolution in bone marrow failure

ESH eLearning, Alan List, 336795

Keynote Discussion

ESH eLearning, Lucio Luzzatto, 336794

KEYNOTE PRESENTATION: PNH as paradigm of the mutability of bone marrow failure

ESH eLearning, Lucio Luzzatto, 336793

Discussion

ESH eLearning, Faculty / Presenters, 336792

Selected brief oral communication: Single Cell eQTL Mapping Identifies Cell-Type Specific Control of Autoimmune Disease

ESH eLearning, Kirsten Fairfax, 336791

Modern diagnosis of aplastic anaemia and PNH

ESH eLearning, Austin Kulasekararaj, 336790

Pathophysiology of PNH

ESH eLearning, Rosario Notaro, 336789

Pathophysiology of immune aplastic anaemia

ESH eLearning, Neal Young, 336788

SATELLITE SYMPOSIUM: Beyond current endpoints: a patient-centric approach to PNH treatment

ESH eLearning, Régis Peffault de, 336787

Discussion

ESH eLearning, Faculty / Presenters, 336786

Selected brief oral communication: Natural History and Outcomes Depending on Organ System Involvement in Patients with Clinically-Relevant Short Telomeres

ESH eLearning, Abhishek Mangaonkar, 336785

Dyskeratosis congenita and related haematological diseases

ESH eLearning, Inderjeet Dokal, 336784

Discussion

ESH eLearning, Faculty / Presenters, 336783

Management of ribosomopathies

ESH eLearning, Yigal Dror, 336782

Diamond-Blackfan anaemia (DBA), ribosomes and haematopoiesis

ESH eLearning, Vijay Sankaran, 336781

Discussion

ESH eLearning, Faculty / Presenters, 336780

Classical and new treatment of Fanconi anaemia

ESH eLearning, Carlo Dufour, 336779

Selected brief oral communication: Immunologic Basis to Poor Graft Function Post Allogeneic Transplantation

ESH eLearning, Ashvind Prabahran, 336778

Panel discussion

ESH eLearning, Faculty / Presenters, 314113

Amyloidosis

ESH eLearning, Giampaolo Merlini, 314112

POEMS

ESH eLearning, Arnaud Jaccard, 314111

Waldenstrom’s disease

ESH eLearning, Jorge Castillo, 314110

Panel discussion

ESH eLearning, Faculty / Presenters, 314109

Bureaucracy is strangling clinical research

ESH eLearning, Steven Le Gouill, 314108

iStopMM-a nationwide screening for MGUS and myeloma and early treatment of smoldering myeloma

ESH eLearning, SIGURDUR KRISTINSSON, 314107

Panel discussion

ESH eLearning, Faculty / Presenters, 314106

Novel immunotherapies (part 2)

ESH eLearning, Sagar Lonial, 314105

Novel immunotherapies (part 1)

ESH eLearning, Hermann Einsele, 314104

Novel targeted therapies (not immune)

ESH eLearning, Shaji Kumar, 314103

Panel discussion

ESH eLearning, Faculty / Presenters, 314102

Update of CARTITUDE-1: A Phase 1b/2 Study of JNJ-68284528 (JNJ-4528), a B-Cell maturation antigen (BCMA)-directed chimeric antigen receptor T (CAR-T) Cell therapy, in relapsed/refractory multiple myeloma (MM)

ESH eLearning, Deepu Madduri, 314101

Overview immune therapies?

ESH eLearning, Noopur Raje, 314100

Beyond 2nd relapse

ESH eLearning, Saad Usmani, 314099

How to sequence in 1st and 2nd relapse?

ESH eLearning, Meletios Dimopoulos, 314098

Panel discussion

ESH eLearning, Faculty / Presenters, 314097

How MRD assessment will impact clinical management

ESH eLearning, Noemi Puig, 314096

MRD and immune profiling (differences in terms of response)

ESH eLearning, Bruno Paiva, 314095

MRD and imaging

ESH eLearning, Elena Zamagni, 314094

Maintenance therapy

ESH eLearning, Graham Jackson, 314092

Panel discussion

ESH eLearning, Faculty / Presenters, 314090

Overview phase 3 trials and newly approved treatments

ESH eLearning, Xavier Leleu, 314087